ClinicalTrials.gg
RecruitingNCT06586541Family-ICUUpdated Aug 14, 2026

The Family-ICU Trial

An interventional study of Participation in attending team rounds in Family Engagement, Patient and Family Engagement and Health Care Delivery, sponsored by Lady Davis Institute. Recruiting at 2 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Lady Davis Institute · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
194
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Family inclusion in adult intensive care unit (ICU) rounds is recommended by critical care professional societies, yet widespread uptake of this practice is limited. A key barrier cited by ICU clinicians is insufficient evidence to support this practice. There is a need for robust evidence to support family participation in adult ICU rounds and influence change to routine clinical care. The primary purpose of this study is to assess whether family participation in adult ICU rounds improves family engagement in care. The secondary objectives are to assess family satisfaction, and anxiety and depression, to explore user experiences of family participation in ICU rounds, and to evaluate strategies to improve family member recruitment and retention rates. This is a stepped-wedge cluster randomized trial (n=194) at 6 Canadian ICUs. The stepped wedge cluster randomized trial is a pragmatic study design that overcomes methodological limitations in evaluating a healthcare service delivery intervention. In the stepped-wedge cluster design, there is random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed. The stepped-wedge design also allows each site to function as its own control. The stepped-wedge design is more powerful than a parallel design when substantial cluster level effects are present.

02

Conditions studied

  • Family Engagement
  • Patient and Family Engagement
  • Health Care Delivery
  • Family-centered Care
  • Physician Rounds
  • Critical Care, Intensive Care

Keywords

  • Patient- and Family-Centered
  • Patient- and Family-Centered Care
  • Family Engagement
  • Critical Care
  • Intensive Care Unit
  • Person-Centered Care
  • Delivery of Health Care
  • Family Participation in Rounds
  • Physician Rounds
03

In context

Lead sponsor

Lady Davis Institute is the lead sponsor of 46 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult family members (age ≥ 18 years) of ICU patients
  • Expected ICU stay ≥ 48 hours

Exclusion criteria

Exclusion Criteria:

  • Family members who do not wish to participate in care
  • Repeat admissions within the study period
  • Another family member has already participated in the study
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
194 participants (estimated)

Study arms

  • No intervention
    Phase 1 (Control group)

    Participants will be able to engage in care as per current family engagement practices. Family members in the usual care group will not participate in daily ICU rounds. In-person family participation in rounds is not routinely performed at any of the trial sites.

  • Experimental
    Phase 2 (Intervention)

    Participants in the Intervention group will be invited to participate in attending team rounds.

    Other: Participation in attending team rounds

Interventions

  • OtherParticipation in attending team rounds

    Family members participate in-person. If the family member wishes to participate in-person, they will be invited to be present when the team rounds in the ICU.

06

What researchers measure

Primary outcomes

  1. FAMily Engagement (FAME) score within 1 week of ICU discharge

    The FAMily Engagement (FAME) tool is a self-administered 12-item questionnaire that assesses an individual's current engagement practice. FAME uses a five-point Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree), and scale results are changed to a 0-100 scoring system, with higher scores indicating greater engagement in care. The following subdomains are evaluated: engagement perception, family presence, communication, education, decision-making, care contribution, and family needs. FAME includes the following engagement domains: family presence, family needs, communication and education, decision making, and direct care. FAME also captures the following family-centered care principles: dignity and respect, information sharing, participation, and collaboration.

    Time frame: 1-week post-hospital discharge

  2. Quality of communication (QOC score)

    The Quality of Communication tool is a 13-item questionnaire that was developed and validated in an ICU setting to measure the perceived quality of communication. Scores range from 0 to 100, with higher scores indicating better clinician-family communication.

    Time frame: 1-week post-hospital discharge

Secondary outcomes

  1. Anxiety and depression (HADS)

    The Hospital Anxiety and Depression Scale (HADS) is a simple to use, validated, and widely used self-reported tool to measure anxiety and depression in medical patients. The survey is composed of 14 questions: 7 depression-related and 7 anxiety-related questions. The score for each item ranges from 0 to 3, and subscale scores greater than 8 denotes anxiety or depression.

    Time frame: 6 months post-hospital discharge

  2. Anxiety and depression (HADS)

    The Hospital Anxiety and Depression Scale (HADS) is a simple to use, validated, and widely used self-reported tool to measure anxiety and depression in medical patients. The survey is composed of 14 questions: 7 depression-related and 7 anxiety-related questions. The score for each item ranges from 0 to 3, and subscale scores greater than 8 denotes anxiety or depression.

    Time frame: 1-week post-hospital discharge

  3. Post-traumatic stress (IES-Revised)

    The IES-Revised is a 22-item questionnaire that has been validated and is widely used for measuring post-traumatic stress symptoms and yields a total score ranging from 0 to 88 and subscale scores for the Intrusion, Avoidance, and Hyperarousal subscales. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). High scores indicate greater severity of PTSD.

    Time frame: 6 months post-hospital discharge

  4. Family satisfaction in the ICU (FS-ICU)

    The Family Satisfaction in the ICU survey (FS-ICU) is a 24-item instrument that was developed and validated to assess family satisfaction and experience with care in the ICU. Scores range from 0 to 100, with higher scores indicate greater satisfaction.

    Time frame: 1-week post-hospital discharge

  5. Quality of life (EuroQOL-5D-5L score)

    The EuroQOL-5D-5L is a 5-item questionnaire that has been validated and is widely used for measuring health-related quality of life. Each dimension has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). The scores are combined to generate a single index value for overall health status. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state

    Time frame: 6 months post-hospital discharge

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06586541
Lead sponsor
Lady Davis Institute
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Michael Goldfarb (Attending Staff, Division of Cardiology, Lady Davis Institute) — Principal investigator
First posted
Sep 19, 2024
Start date
Nov 18, 2024
Primary completion
Feb 2028 (estimated)
Completion
Jul 2029 (estimated)
Last update
Aug 14, 2026

Study contacts

Kabisan Vilvaratnam
Contact
kabisan.vilvaratnam.ccomtl@ssss.gouv.qc.ca
5143408222 ext. 25806
Michael J Goldfarb, MD, MSc
principal investigator · Lady Davis Institute, McGill University, Jewish General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion